CVS Health Corp.’s CVS Caremark prescription drug-benefits manager spent Tuesday trying to return to normal following delays that began on Monday, according to the Wall Street Journal late Tuesday. CVS sent letters to pharmacies nationwide warning of an “unexpected system slowdown,” and that operations were back to normal, the Journal reported. Backlogged orders, however, could cause “temporary delays,” the company said. A request for comment from CVS had not been returned by time of publication. CVS shares were down less than 0.1% after hours, following a 2.8% rise to close the regular session at $71.27.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
0
0
